Topic 2: OUD and Co-Morbid Conditions

Practice gaps include the consistent integration of psychiatric and addiction treatment, providing trauma informed care in this setting, and utilizing addiction informed care from a neuropsychiatric perspective.  While the understanding of addiction as a disease of the brain has been widely studied and established, the stigma of addictive disorders remains a major barrier for...

Faculty

• Chris Stewart , MD

Practice gaps include the consistent integration of psychiatric and addiction treatment, providing trauma informed care in this setting, and utilizing addiction informed care from a neuropsychiatric perspective.  While the understanding of addiction as a disease of the brain has been widely studied and established, the stigma of addictive disorders remains a major barrier for...

Faculty

• Chris Stewart , MD

Pain is often misunderstood and not adequately treated by providers. Additionally, studies have shown that there is a provider bias when treating non-white patients for chronic pain.  As a result, additional training is needed for providers treating patients with chronic pain.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Pain is often misunderstood and not adequately treated by providers. Additionally, studies have shown that there is a provider bias when treating non-white patients for chronic pain.  As a result, additional training is needed for providers treating patients with chronic pain.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Stimulant use, particularly methamphetamine use, has significant adverse effects on the brain and body.  As stimulant use has increased, medical consequences such as overdose and need for hospitalization are rising. Stimulant use presents unique challenges also for addiction medicine providers treating opioid use disorder. Unlike treatment for opioid use disorder, there are no...

Faculty

• Danielle Anderson , MD

Stimulant use, particularly methamphetamine use, has significant adverse effects on the brain and body.  As stimulant use has increased, medical consequences such as overdose and need for hospitalization are rising. Stimulant use presents unique challenges also for addiction medicine providers treating opioid use disorder. Unlike treatment for opioid use disorder, there are no...

Faculty

• Danielle Anderson , MD

Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals including healthcare professionals are not familiar with this substance and its adverse effects. This presentation will review the best practices in identifying people using...

Faculty

• Kelly S. Ramsey , MD MPH, MA FACP, DFASAM

Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals including healthcare professionals are not familiar with this substance and its adverse effects. This presentation will review the best practices in identifying people using...

Faculty

• Kelly S. Ramsey , MD MPH, MA FACP, DFASAM

Individuals that use opioids often use cannabinoids as well.  However, there are many unknowns Faculty

• Shanna Babalonis , PhD

There is an estimated 3.7 million adults who inject drugs in the...

Faculty

• Laura C. Fanucchi , MD, MPH

Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and...

Faculty

• Daniel T. Weaver , MD, FACP, FASAM

Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and...

Faculty

• Daniel T. Weaver , MD, FACP, FASAM